TRY NOW

Enhance and accelerate your early stage research with trusted and comprehensive intelligence from Thomson Reuters.

Start your free trial in just two simple steps.

Get your FREE trial

Enrich your discovery science with market leading, manually curated scientific intelligence. Systems Biology, Preclinical, Biomarkers, Chemistry, Biology, and Pharmacology - and everything in between. Covered from the perspective that matters most – yours.
Customer Feedback
Customer Feedback

Annette Bakker, Chief Scientific Officer from CTF, explains the reasons why she likes to work with Thomson Reuters. Currently using MetaCore™ to identify disease treatment options.

Live & Recorded Training

Attend one of our regularly scheduled webinar training sessions for overviews of features, tools, and content – find the schedule here

Free Pathway Maps

Search or browse through a wide range of proprietary multi-step canonical pathway maps here.

Featured News

The latest news from Life Sciences Research
The future of COPD treatment

The future of COPD treatment

Our research shows greater focus on preventative therapies

Translational Medicine

Translational Medicine

Supplement-Size Doses of Antioxidants Hasten Lung Cancer Progression

Tet Proteins Erase Epigenetic Marks

Tet Proteins Erase Epigenetic Marks

It is (reasonably) common knowledge that DNA is written in a simple four-letter code: ACTG. Too simple, actually.

Blog Highlights

Read our latest blog posts

With Great Opportunity Comes Great Challenges in the 3-D Printing Space

Spider-Man fans know that with great power comes great responsibility. The same could be said of using 3-D printing, also known as additive manufacturing, in ...

Partnering Returned Assets can Rescue, Maximize Value

Deal terminations can throw even the most confident companies for a loop, dealing a blow to the perceived value of even still-promising assets. Finding a ...

The ‘Danger Theory’ of Immune Recognition: 60 Years on from ‘Self Non-Self’

Inducing tissue damage and inflammation to eliminate disease is a long established clinical concept. Historically, Hippocrates is claimed to have said, “Give me the power ...

Whitepapers & Publications

View our recent whitepapers and publications

BioMarker White Paper

White paper establishing the standards in biomarker research.

Thomson Reuters Professional Services White Paper

Knowledge-Based Drug Repositioning to Drive R&D Productivity

Thomson Reuters Professional Services Report

The economic power of orphan drugs

Latest on Twitter

Latest on Linked In